Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Early antiretroviral therapy improves neurodevelopmental outcomes in infants.

Laughton B, Cornell M, Grove D, Kidd M, Springer PE, Dobbels E, van Rensburg AJ, Violari A, Babiker AG, Madhi SA, Jean-Philippe P, Gibb DM, Cotton MF.

AIDS. 2012 Aug 24;26(13):1685-90.

2.

Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial.

Cotton MF, Violari A, Otwombe K, Panchia R, Dobbels E, Rabie H, Josipovic D, Liberty A, Lazarus E, Innes S, van Rensburg AJ, Pelser W, Truter H, Madhi SA, Handelsman E, Jean-Philippe P, McIntyre JA, Gibb DM, Babiker AG; CHER Study Team.

Lancet. 2013 Nov 9;382(9904):1555-63. doi: 10.1016/S0140-6736(13)61409-9.

3.

Reactivity of routine HIV antibody tests in children who initiated antiretroviral therapy in early infancy as part of the Children with HIV Early Antiretroviral Therapy (CHER) trial: a retrospective analysis.

Payne H, Mkhize N, Otwombe K, Lewis J, Panchia R, Callard R, Morris L, Babiker A, Violari A, Cotton MF, Klein NJ, Gibb DM.

Lancet Infect Dis. 2015 Jul;15(7):803-9. doi: 10.1016/S1473-3099(15)00087-0. Epub 2015 Jun 1.

4.

Neurodevelopmental delay among HIV-infected preschool children receiving antiretroviral therapy and healthy preschool children in Soweto, South Africa.

Lowick S, Sawry S, Meyers T.

Psychol Health Med. 2012;17(5):599-610. doi: 10.1080/13548506.2011.648201. Epub 2012 Feb 7.

PMID:
22313239
5.

Cognitive function and neurodevelopmental outcomes in HIV-infected Children older than 1 year of age randomized to early versus deferred antiretroviral therapy: the PREDICT neurodevelopmental study.

Puthanakit T, Ananworanich J, Vonthanak S, Kosalaraksa P, Hansudewechakul R, van der Lugt J, Kerr SJ, Kanjanavanit S, Ngampiyaskul C, Wongsawat J, Luesomboon W, Vibol U, Pruksakaew K, Suwarnlerk T, Apornpong T, Ratanadilok K, Paul R, Mofenson LM, Fox L, Valcour V, Brouwers P, Ruxrungtham K; PREDICT Study Group.

Pediatr Infect Dis J. 2013 May;32(5):501-8. doi: 10.1097/INF.0b013e31827fb19d.

6.

Early antiretroviral treatment reduces risk of bacille Calmette-Guérin immune reconstitution adenitis.

Rabie H, Violari A, Duong T, Madhi SA, Josipovic D, Innes S, Dobbels E, Lazarus E, Panchia R, Babiker AG, Gibb DM, Cotton MF; CHER team.

Int J Tuberc Lung Dis. 2011 Sep;15(9):1194-200, i. doi: 10.5588/ijtld.10.0721.

7.

HIV-associated neurodevelopmental delay: prevalence, predictors and persistence in relation to antiretroviral therapy initiation and viral suppression.

Strehlau R, Kuhn L, Abrams EJ, Coovadia A.

Child Care Health Dev. 2016 Nov;42(6):881-889. doi: 10.1111/cch.12399. Epub 2016 Aug 22.

PMID:
27546069
8.

Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection.

Chiappini E, Galli L, Tovo PA, Gabiano C, Gattinara GC, Guarino A, Badolato R, Giaquinto C, Lisi C, de Martino M; Italian Register for HIV Infection in Children.

AIDS. 2006 Jan 9;20(2):207-15. Erratum in: AIDS. 2006 Aug 22;20(13):1789. Baddato, Raffaele [corrected to Badolato, Raffaele].

PMID:
16511413
9.

Comparison of developmental milestone attainment in early treated HIV-infected infants versus HIV-unexposed infants: a prospective cohort study.

Benki-Nugent S, Wamalwa D, Langat A, Tapia K, Adhiambo J, Chebet D, Okinyi HM, John-Stewart G.

BMC Pediatr. 2017 Jan 17;17(1):24. doi: 10.1186/s12887-017-0776-1.

10.

Massage therapy improves the development of HIV-exposed infants living in a low socio-economic, peri-urban community of South Africa.

Perez EM, Carrara H, Bourne L, Berg A, Swanevelder S, Hendricks MK.

Infant Behav Dev. 2015 Feb;38:135-46. doi: 10.1016/j.infbeh.2014.12.011. Epub 2015 Jan 31.

PMID:
25645599
11.

Early severe HIV disease precedes early antiretroviral therapy in infants: Are we too late?

Innes S, Lazarus E, Otwombe K, Liberty A, Germanus R, Van Rensburg AJ, Grobbelaar N, Hurter T, Eley B, Violari A, Cotton MF.

J Int AIDS Soc. 2014 Jun 11;17:18914. doi: 10.7448/IAS.17.1.18914. eCollection 2014.

12.

Increased microbial translocation in ≤ 180 days old perinatally human immunodeficiency virus-positive infants as compared with human immunodeficiency virus-exposed uninfected infants of similar age.

Papasavvas E, Azzoni L, Foulkes A, Violari A, Cotton MF, Pistilli M, Reynolds G, Yin X, Glencross DK, Stevens WS, McIntyre JA, Montaner LJ.

Pediatr Infect Dis J. 2011 Oct;30(10):877-82. doi: 10.1097/INF.0b013e31821d141e.

13.

Treatment interruption after 2-year antiretroviral treatment initiated during acute/early HIV in infancy.

Wamalwa D, Benki-Nugent S, Langat A, Tapia K, Ngugi E, Moraa H, Maleche-Obimbo E, Otieno V, Inwani I, Richardson BA, Chohan B, Overbaugh J, John-Stewart GC.

AIDS. 2016 Sep 24;30(15):2303-13. doi: 10.1097/QAD.0000000000001158.

14.

Longitudinal developmental profile of children from low socio-economic circumstances in Cape Town, using the 1996 Griffiths Mental Development Scales.

Laughton B, Springer P, Grove D, Seedat S, Cornell M, Kidd M, Madhi S, Cotton M.

SAJCH. 2010 Dec;4(4):106-111.

15.

Hospitalization trends, costs, and risk factors in HIV-infected children on antiretroviral therapy.

Collins IJ, Cairns J, Jourdain G, Fregonese F, Nantarukchaikul M, Lertpienthum N, Wannarit P, Attavinijtrakarn P, Layangool P, Le Coeur S, Lallemant M; Program for HIV Prevention and Treatment (PHPT) study team.

AIDS. 2012 Sep 24;26(15):1943-52.

PMID:
22824633
16.

Early Antiretroviral Therapy reduces the incidence of otorrhea in a randomized study of early and deferred antiretroviral therapy: Evidence from the Children with HIV Early Antiretroviral Therapy (CHER) Study.

Hainline C, Taliep R, Sorour G, Nachman S, Rabie H, Dobbels E, van Rensburg AJ, Cornell M, Violari A, Madhi SA, Cotton MF.

BMC Res Notes. 2011 Oct 26;4:448. doi: 10.1186/1756-0500-4-448.

17.

The prevalence of motor delay among HIV infected children living in Cape Town, South Africa.

Ferguson G, Jelsma J.

Int J Rehabil Res. 2009 Jun;32(2):108-14. doi: 10.1097/MRR.0b013e3283013b34.

PMID:
19384238
18.

The long-term effectiveness of generic adult fixed-dose combination antiretroviral therapy for HIV-infected Ugandan children.

Barlow-Mosha LN, Bagenda DS, Mudiope PK, Mubiru MC, Butler LM, Fowler MG, Musoke PM.

Afr Health Sci. 2012 Sep;12(3):249-58.

19.

Randomized controlled trial of trained patient-nominated treatment supporters providing partial directly observed antiretroviral therapy.

Nachega JB, Chaisson RE, Goliath R, Efron A, Chaudhary MA, Ram M, Morroni C, Schoeman H, Knowlton AR, Maartens G.

AIDS. 2010 Jun 1;24(9):1273-80. doi: 10.1097/QAD.0b013e328339e20e.

20.

Growth in HIV-infected children on long-term antiretroviral therapy.

Feucht UD, Van Bruwaene L, Becker PJ, Kruger M.

Trop Med Int Health. 2016 May;21(5):619-29. doi: 10.1111/tmi.12685. Epub 2016 Mar 21.

Supplemental Content

Support Center